Results
901
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
901 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MDC | €29.60 | 8.8% | 41.0% | €125.0m | €31.40 | PE42.1x | E37.5% | n/a | Healthcare | ||
WIX | US$147.93 | -4.8% | 48.0% | US$8.7b | US$184.72 | PE122.7x | E34.1% | n/a | Software | ||
IDR | €18.20 | -5.4% | 34.8% | €3.2b | €22.97 | PE13.8x | E12.0% | 1.4% | Software | ||
RSL2 | €18.20 | -2.2% | -17.3% | €117.2m | €30.00 | PB1.7x | E58.9% | 0% | Capital Goods | ||
BWMN | US$33.94 | -2.0% | -3.3% | US$631.0m | US$43.25 | PS1.6x | E150.4% | n/a | Capital Goods | ||
MYFW | US$17.25 | -7.1% | -16.8% | US$175.2m | US$21.33 | PB0.7x | E83.3% | n/a | Banks | ||
EGLA | €3.41 | -1.9% | -37.6% | €555.3m | €5.32 | PE16.4x | E26.6% | 1.2% | Capital Goods | ||
VRTX | US$505.78 | 2.7% | 45.4% | US$127.9b | US$483.96 | PE32.5x | E17.4% | n/a | Pharmaceuticals & Biotech | ||
MNTK | US$5.79 | -1.2% | -32.2% | US$843.8m | US$7.06 | PE40x | E20.1% | n/a | Utilities | ||
BHG | SEK 15.07 | -4.4% | -19.7% | SEK 2.7b | SEK 19.00 | PB0.4x | E132.8% | n/a | Retail | ||
BFF | €10.11 | -3.4% | 5.1% | €1.9b | €11.20 | PE11.6x | E15.1% | 10.7% | Diversified Financials | ||
285 | HK$29.30 | -4.7% | -3.3% | HK$66.0b | HK$42.96 | PE15.1x | E22.3% | 2.0% | Tech | ||
PCO | zł18.90 | 0.9% | -44.1% | zł10.9b | zł29.73 | PE21.2x | E31.4% | n/a | Retail | ||
HEG | ₹2,151.30 | 1.8% | 20.2% | ₹83.0b | ₹2,610.00 | PE26.6x | E42.6% | 1.0% | Capital Goods | ||
AR | US$28.77 | -1.5% | 4.4% | US$9.0b | US$36.18 | PE107.4x | E43.8% | n/a | Energy | ||
8919 | JP¥1,758.00 | -5.2% | -30.0% | JP¥137.1b | JP¥2,416.25 | PE16.1x | E9.1% | 3.2% | Real Estate Management and Development | ||
PSTG | US$56.82 | -1.0% | 51.2% | US$19.5b | US$70.90 | PE197.2x | E32.1% | n/a | Tech | ||
SVED BTA B | SEK 36.30 | 2.8% | n/a | SEK 1.9b | n/a | PE13.8x | E24.9% | n/a | Capital Goods | ||
500 | S$1.68 | 12.0% | -37.8% | S$5.7b | S$2.71 | PB0.9x | E72.2% | 0% | Capital Goods | ||
VCYT | US$22.95 | -3.4% | -9.9% | US$1.8b | US$29.83 | PS4.7x | E122.0% | n/a | Pharmaceuticals & Biotech | ||
NOHO | €8.18 | 2.5% | -11.7% | €171.9m | €10.40 | PE31.8x | E27.9% | 5.3% | Consumer Services | ||
DGC | ₫107,100.00 | -5.4% | 43.8% | ₫40.3t | ₫134,783.33 | PE14.5x | E22.9% | 3.7% | Materials | ||
EFR | CA$7.20 | -7.1% | -11.2% | CA$1.3b | CA$14.90 | PS19.4x | E50.8% | n/a | Energy | ||
NFG | US$59.19 | 3.1% | 10.8% | US$5.4b | US$68.67 | PE17.1x | E26.4% | 3.5% | Utilities |